MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 3, 2012, Pages 697-703

  Nagarajan, Rajakumar ^a   Margolis, Daniel ^a   Raman, Steven ^a   Sarma, Manoj K ^a   Sheng, Ke ^b   King, Christopher R ^b   Verma, Gaurav ^a   Sayre, James ^a   Reiter, Robert E ^b   Thomas, M Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apparent diffusion coefficient; diffusion weighted imaging; Gleason scores; MR spectroscopy; prostate cancer

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TUMOR VOLUME;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84865333666     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23676     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E,. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-916. (Pubitemid 17147932)
3. Smith DS, Catalona WJ,. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 1995; 45: 70-74.
4. Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562-566. (Pubitemid 27433216)
5. Chen ME, Troncoso P, Johnston DA, et al. Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997; 158: 2168-2175. (Pubitemid 27481351)
6. Gleason DF,. Histology grading of prostate cancer: a perspective. Hum Pathol 1992; 23: 273-279.
7. Costello LC, Franklin RB,. Concepts of citrate production and secretion by prostate. I. Metabolic relationships. Prostate 1991; 18: 25-46.
8. Khan T, Beurrig K, Schmitz-Dreager B, et al. Prostatic carcinoma and benign prostatic hyperplasia. Radiology 1989; 173: 847-851.
9. Costello LC, Franklin RB,. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 1998; 35: 285-296. (Pubitemid 28235130)
10. Liang JY, Liu YY, Zou J, et al. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40: 200-207. (Pubitemid 29334868)
11. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 1999; 213: 473-480. (Pubitemid 29510595)
12. Swanson MG, Vigneron DB, Tabatabai ZL, et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 2003; 50: 944-954. (Pubitemid 37356574)
13. Yuen JS, Thng CH, Tan PH, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171: 1482-1486. (Pubitemid 38365401)
14. Yamamura J, Salomon G, Buchert R, et al. Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy. J Comput Assist Tomogr 2011; 35: 223-228.
15. Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011; 259: 453-461.
16. Bittencourt LK, Barentsz JO, de Miranda LC, et al. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol 2012; 22: 468-475.
17. Itou Y, Nakanishi K, Narumi Y, Nishizawa Y, Tsukuma H,. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? J Magn Reson Imaging 2011; 33: 167-172.
18. Kirkham APS, Emberton M, Allen C,. How good is MRI at detecting and characterising cancer within the prostate? Eur Radiol 2006; 50: 1163-1175. (Pubitemid 44692933)
19. Kurhanewicz J, Vigneron DB,. Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am 2008; 16: 697-710.
20. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792. (Pubitemid 43830614)
21. Fütterer JJ, Engelbrecht MR, Jager GJ, et al. Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 2007; 17: 1055-1065. (Pubitemid 46766887)
22. Costouros NG, Coakley FV, Westphalen AC, et al. Diagnosis of prostate cancer in patients with elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopy imaging. Am J Roentgenol 2007; 188: 812-816.
23. Westphalen AC, Coakley FV, Qayyum A, et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology 2008; 246: 177-184. (Pubitemid 350305041)
24. Sato C, Naganawa S, Nakumara T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21: 258-262. (Pubitemid 40280120)
25. Mescher M, Tannus A, Johnson MO, et al. Solvent suppression using selective echo dephasing. J Magn Reson A 1996; 123: 226-229. (Pubitemid 126752021)
26. Noworolski SM, Crane JC, Vigneron DB, Kurhanewicz J,. A clinical comparison of rigid and inflatable endorectal-coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate. J Magn Reson Imaging 2008; 27: 1077-1082. (Pubitemid 351614619)
27. 3) spatial resolution. Radiology 1996; 198: 795-805. (Pubitemid 26066301)
28. Kumar V, Jagannathan NR, Kumar R, et al. Potential of (1)HMR spectroscopic imaging to segregate patients who are likely to show malignancy of the peripheral zone of the prostate on biopsy. J Magn Reson Imaging 2009; 30: 842-848.
29. 1HMR spectroscopic imaging: correlation with pathologic findings. Abdom Imaging 2010; 35: 757-763.
30. Zakian KL, Sircar K, Kleinman S, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step section radical prostatectomy (abstract). Radiology 2002; 225: 1525.
31. Chen ME, Troncoso P, Johnston DA, et al. Functional MR imaging of prostate cancer. Radiographics 2007; 27: 63-75.
32. Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, et al. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Eur Urol 2011; 60: 1074-1080.
33. Augustin H, Hammerer PG, Graefen M, et al. Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy. J Cancer Res Clin Oncol 2003; 129: 662-668. (Pubitemid 37452633)
34. Eichelberger LE, Koch MO, Daggy JK, et al. Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer. Am J Clin Pathol 2003; 120: 386-391. (Pubitemid 37295109)
35. Kumar V, Jagannathan NR, Kumar R, et al. Apparent diffusion coefficient of the prostate in men prior to biopsy: determination of a cut-off value to predict malignancy of the peripheral zone. NMR Biomed 2007; 20: 505-511 (Pubitemid 47272370)
36. Tanimoto A, Nakashima J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-152. (Pubitemid 46095209)
37. DeSouza NM, Reinsberg SA, Scurr ED, et al. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007; 80: 90-95. (Pubitemid 46951251)
38. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005; 29: 149-153. (Pubitemid 40411296)
39. Hosseinzadeh K, Schwarz SD,. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004; 20: 654-661. (Pubitemid 39313742)
40. Anderson JR,. Muir's textbook of pathology. London: Edward Arnold; 1985.
41. Mazaheri Y, Hricak H, Fine SW, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009; 252: 449-457.
42. Miao H, Fukatsu H, Ishigaki T,. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. Eur J Radiol 2007; 61: 297-302. (Pubitemid 46096691)
43. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008; 27: 132-139.
44. Kim CK, Choi D, Park BK, et al. Diffusion weighted MR imaging for the evaluation of SVI in prostate cancer: initial results. J Magn Reson Imaging 2008; 28: 963-969
45. Chen M, Dang HD, Wang JY, et al. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 2008; 49: 602-610.
46. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007; 188: 91-98. (Pubitemid 46012494)